Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00820781 · ClinicalTrials.gov registry record · NA
Endoscopic Sclerotherapy and/or Ligation Versus Portacaval Shunt for Bleeding Gastric Varices
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 518
- Enrollment target
NCT00820781 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 518 participants.
The verdict
NCT00820781, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 518 participants
- Enrollment target
Study Summary
In unselected cirrhotic patients with bleeding gastric varices to compare the influence on mortality rate, duration of life, control of bleeding, quality of life, and economic costs of treatment of: portacaval shunt, endoscopic variceal sclerotherapy and/or variceal ligation.
Interventions
- PROCEDURE Portacaval shunt
- PROCEDURE Sclerotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 518 participants |
| Start Date | 1977-08 |
| Est. Completion | 2003-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00820781
The ClinicalTrials.gov registry entry for NCT00820781 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 518 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Portacaval shunt is the first listed.
NCT00820781 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00820781 about?
NCT00820781 is a clinical study titled "Endoscopic Sclerotherapy and/or Ligation Versus Portacaval Shunt for Bleeding Gastric Varices". In unselected cirrhotic patients with bleeding gastric varices to compare the influence on mortality rate, duration of life, control of bleeding, quality of life, and economic costs of treatment of: portacaval shunt, endoscopic variceal sclerotherapy and/or variceal ligation.
What is the current status of trial NCT00820781?
This trial is currently completed. It is a NA study. The enrollment target is 518 participants. The study started on 1977-08. Estimated completion is 2003-04.
What interventions are being tested in trial NCT00820781?
The interventions under investigation include: Portacaval shunt (PROCEDURE), Sclerotherapy (PROCEDURE).
Who is sponsoring clinical trial NCT00820781?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.